Navigation Links
PRISM Pharma Closes $15 million Series C Financing to Advance PRI-724 into Non-oncology Indications
Date:6/12/2013

YOKOHAMA, Japan, June 13, 2013 /PRNewswire/ -- PRISM Pharma Co., Ltd., a drug discovery company focused on developing small molecule technologies that modulate protein-protein interactions, today announced the close of an approximately $15 million (approximately ¥1.4 billion) Series C financing. This funding was led by Innovation Network Corporation of Japan, a unique public-private partnership aimed at promoting innovation and enhancing the value of Japanese businesses. Existing investor Development Bank of Japan also participated in the round. Proceeds will be used to fund clinical trials of PRISM's lead compound, PRI-724, for the treatment of fibrosis and other related conditions.

PRI-724 modulates signaling of the Wnt/beta-catenin signaling pathway, shifting from symmetric to asymmetric cell division resulting in a shift from proliferation towards differentiation.  Excessive proliferation is a hallmark of cancer and can also result in damaging fibrosis in diseases such as hepatitis-driven cirrhosis, Idiopathic Pulmonary Fibrosis (IPF) and renal disease, as well as many skin and eye conditions. There is no effective means to reverse fibrosis, and treatment is limited to slowing disease progression. In animal models, PRI-724 has reversed the formation of excessive fibrous connective tissue, demonstrating its potential to treat fibrosis in several indications including Hepatitis C and IPF. PRISM plans to start a fibrosis clinical trial in the fall and expects to obtain efficacy data from this and additional clinical trials by early 2015.

"Targeting the pathways that control cellular differentiation and proliferation has potential to treat a range of conditions that are driven by cell division, including fibrosis, cancer, and other proliferative diseases," said Hiroyuki Kouji, CEO of PRISM Pharma. "We have already made significant strides in studying PRI-724 in
'/>"/>

SOURCE PRISM Pharma Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Founder of Nestle-Acquired Company Joins Prismic Pharmaceuticals
2. Anthera Pharmaceuticals Announces Personnel Changes
3. New National Sterile Compounding Pharmacy Network to Revolutionize Ambulatory Surgery Center Access to Medications
4. Zydus Pharmaceuticals USA Inc. Issues Voluntary Nationwide Recall of Warfarin 2 mg Tablets, Lot MM5767, Expiration Date June 2014, Due to Oversized Tablets
5. QRxPharma Granted US Patent On Hybrid Opioids
6. Catalent Pharma Solutions Breaks Ground On A Major Expansion Of Its Winchester, Kentucky Controlled Release Manufacturing Facility
7. Ohr Pharmaceutical Announces Approval for Listing on NASDAQ
8. GDS International Leads the Way for the Pharmaceutical Industry at its Upcoming NGP DD 30 Summit in Madrid
9. PDL BioPharma Provides Second Quarter 2013 Royalty Revenue Guidance of $143 Million
10. Royalty Pharma Files Judicial Review Proceedings
11. Pointlogic and Kantar Media Announce Dedicated Communication Planning Solution for Pharmaceutical Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... BALTIMORE and LONDON , Aug. 28, ... volunteers in the UK, The Gambia and ... of an series of safety trials of potential vaccines aimed at ... the current outbreak in West Africa . ... US National Institutes of Health (NIH) and GlaxoSmithKline, are to be ...
(Date:8/28/2014)... CHARLOTTE, N.C. , Aug. 28, 2014 /PRNewswire/ ... innovation marketplace, today announced a worldwide search for ... of the senior population.  Promising ideas uncovered through ... presented to leading medical device manufacturers and healthcare ... to improve the lives of individuals age 65 ...
(Date:8/28/2014)... 28, 2014 According to a ... Identification (RFID) Market (Tags, Readers, Middleware, Printers and Cabinets) ... Forecast, 2014 - 2020" the global radiofrequency identification (RFID) ... and is expected to grow at a CAGR of ... value of USD 5.3 billion in 2020. ...
Breaking Medicine Technology:Ebola vaccine trials fast-tracked by international consortium 2Ebola vaccine trials fast-tracked by international consortium 3Ebola vaccine trials fast-tracked by international consortium 4Ebola vaccine trials fast-tracked by international consortium 5Ebola vaccine trials fast-tracked by international consortium 6Ebola vaccine trials fast-tracked by international consortium 7Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 4Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 5
... 16, 2010 See video from Siemens Corporation ... Say so-long to the days of black ... to MRI and PET, medical imaging is faster, ... way medicine is practiced. Thanks to years of ...
... Unsustainable Medicare reimbursement rates for home medical equipment ... providers will occur as a result of Medicare,s bidding ... nine of the largest metropolitan areas in the U.S. ... Dallas-Fort Worth, Kansas City, Miami, Orlando, Pittsburgh, and Riverside, ...
Cached Medicine Technology:VIDEO from Siemens Corporation Available on thenewsmarket.com: Amazing Medical Images: Diagnosing in the Digital Age 2Problems Emerge in Competitive Bidding Pricing Scheme for Home Medical Equipment; Economists Predict the Program Will Fail 2Problems Emerge in Competitive Bidding Pricing Scheme for Home Medical Equipment; Economists Predict the Program Will Fail 3
(Date:8/28/2014)... A subset of patients with stage III colon ... therapy, according to a new study in ... the American Gastroenterological Association. , When added to the ... irinotecan therapy improved overall survival rates for patients with ... in about 10 to 20 percent of colorectal cancers. ...
(Date:8/28/2014)... over who identify themselves as ,old, feel worse about ... have lower value than younger age groups. , New ... ,Being old and ill, across different countries: social status, ... from the European Social Survey. Respondents, who were all ... health., The researchers found that those living in societies ...
(Date:8/28/2014)... Manchester scientists are working out how to safely increase ... potentially offering improved local control and survival. , Standard ... a combination of radiotherapy and chemotherapy. Traditionally this is ... may not always be enough to stop tumour growth. ... the cancerous tissue varies between patients and depends on ...
(Date:8/28/2014)... 2014 Vaccine market - the once ... among other healthcare industry sectors and sub-circles in the ... vaccine with respect to evolving and spreading infectious diseases. ... an improved understanding for a well-balanced life and improved ... has led to new opportunities for manufacturing novel preventive ...
(Date:8/28/2014)... August 28, 2014 AmeriPride Services, a ... today announced the launch of its new Customer Portal, ... even easier and more convenient for customers. The industry-leading ... and better communicate with the company. , Features of ... Access, download and pay bills online ...
Breaking Medicine News(10 mins):Health News:Drug shows promise for subset of stage III colon cancer patients 2Health News:Research demonstrates potential method to better control lung cancer using radiotherapy 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 3Health News:AmeriPride Services Launches New Customer Portal 2Health News:AmeriPride Services Launches New Customer Portal 3
... The Medicare drug program is on its last lap of seeking ... of the plans to rest// with three major insurance players. ... with AARP as its official endorsers and a financial agreement with ... for the drug program by Medicare. ,80 companies have ...
... have been found to be alive in America today. ... management of the disease. // ,However it has ... do suffer from debilitating fatigue making normal activities of life ... California at Los Angeles found that not all survivors suffer ...
... included bestowing nurses and pharmacists with the right to ... and pharmacists can undertake extra training in order to ... to tonsillitis. ,Many nurses already run their ... prescribe drugs even for long-term conditions such as asthma ...
... action against smoking in Scotland, it would stop sales of tobacco ... it. ,Ministers have not decided whether to back the ... determination to reduce smoking rates in Scotland. ,In the ... a member of the expert group, "Smoking is far worse than ...
... non-typical sleep times has the ability to improve an ... Sleep Medicine at Brigham and Women’s Hospital and Harvard ... in order to find out the effectiveness of melatonin. ... travelers with jet lag. br> ,The findings appear in ...
... say that percutaneous image-guided biopsy is of a great ... accurately// diagnosing and predicting clinical outcomes. The researchers arrived ... in 126 patients. They found that the biopsy results ... who were to undergo surgery, tumor ablation, chemotherapy or ...
Cached Medicine News:Health News:Breast Cancer Survivors Growing in Numbers 2Health News:Melatonin Can Help Nighttime Workers Sleep 2Health News:Melatonin Can Help Nighttime Workers Sleep 3Health News:Image-Guided Biopsy Can Alter Clinical Decisions In Kidney Patients 2
Used for the introduction of catheters, balloons and other vascular devices....
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Sheath Introducer featuring patented SLIX Valve, rotating collar, kink-resistant cannula and atraumatic tip transitions....
The TAXUS Express Paclitaxel-Eluting Coronary Stent System is indicated for improving luminal diameter for the treatment of de novo lesions = 28 mm in length in native coronary arteries = 2.5 to = 3....
Medicine Products: